115 related articles for article (PubMed ID: 14738136)
1. The role of DNA hypermethylation in the pathogenesis and prognosis of acute lymphoblastic leukemia.
Roman-Gomez J; Castillejo JA; Jimenez A; Barrios M; Heiniger A; Torres A
Leuk Lymphoma; 2003 Nov; 44(11):1855-64. PubMed ID: 14738136
[TBL] [Abstract][Full Text] [Related]
2. Poor prognosis in acute lymphoblastic leukemia may relate to promoter hypermethylation of cancer-related genes.
Roman-Gomez J; Jimenez-Velasco A; Barrios M; Prosper F; Heiniger A; Torres A; Agirre X
Leuk Lymphoma; 2007 Jul; 48(7):1269-82. PubMed ID: 17613754
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
[TBL] [Abstract][Full Text] [Related]
4. Alterations of DNA methylation in hematologic malignancies.
Rush LJ; Plass C
Cancer Lett; 2002 Nov; 185(1):1-12. PubMed ID: 12142073
[TBL] [Abstract][Full Text] [Related]
5. Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients.
Agirre X; Vizmanos JL; Calasanz MJ; García-Delgado M; Larráyoz MJ; Novo FJ
Oncogene; 2003 Feb; 22(7):1070-2. PubMed ID: 12592393
[TBL] [Abstract][Full Text] [Related]
6. TP53 is frequently altered by methylation, mutation, and/or deletion in acute lymphoblastic leukaemia.
Agirre X; Novo FJ; Calasanz MJ; Larráyoz MJ; Lahortiga I; Valgañón M; García-Delgado M; Vizmanos JL
Mol Carcinog; 2003 Dec; 38(4):201-8. PubMed ID: 14639659
[TBL] [Abstract][Full Text] [Related]
7. Aberrant promoter hypermethylation of selected apoptotic genes in childhood acute lymphoblastic leukemia among North Indian population.
Nikbakht M; Jha AK; Malekzadeh K; Askari M; Mohammadi S; Marwaha RK; Kaul D; Kaur J
Exp Oncol; 2017 Mar; 39(1):57-64. PubMed ID: 28361856
[TBL] [Abstract][Full Text] [Related]
8. Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation.
Li X; Liu J; Zhou R; Huang S; Huang S; Chen XM
Br J Haematol; 2010 Jan; 148(1):69-79. PubMed ID: 19807731
[TBL] [Abstract][Full Text] [Related]
9. Aberrant DNA methylation of key genes and Acute Lymphoblastic Leukemia.
Rahmani M; Talebi M; Hagh MF; Feizi AAH; Solali S
Biomed Pharmacother; 2018 Jan; 97():1493-1500. PubMed ID: 29793312
[TBL] [Abstract][Full Text] [Related]
10. Aberrant DNA methylation and epigenetic inactivation of hMSH2 decrease overall survival of acute lymphoblastic leukemia patients via modulating cell cycle and apoptosis.
Wang CX; Wang X; Liu HB; Zhou ZH
Asian Pac J Cancer Prev; 2014; 15(1):355-62. PubMed ID: 24528056
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional silencing of the Dickkopfs-3 (Dkk-3) gene by CpG hypermethylation in acute lymphoblastic leukaemia.
Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; Barrios M; Andreu EJ; Prosper F; Heiniger A; Torres A
Br J Cancer; 2004 Aug; 91(4):707-13. PubMed ID: 15226763
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of CpG island in the promoter region of CALCA in acute lymphoblastic leukemia with central nervous system (CNS) infiltration correlates with poorer prognosis.
Paixão VA; Vidal DO; Caballero OL; Vettore AL; Tone LG; Ribeiro KB; Lopes LF
Leuk Res; 2006 Jul; 30(7):891-4. PubMed ID: 16712930
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of CpG islands in the promoter region of the p15INK4B gene in childhood acute leukaemia.
Tsellou E; Troungos C; Moschovi M; Athanasiadou-Piperopoulou F; Polychronopoulou S; Kosmidis H; Kalmanti M; Hatzakis A; Dessypris N; Kalofoutis A; Petridou E
Eur J Cancer; 2005 Mar; 41(4):584-9. PubMed ID: 15737564
[TBL] [Abstract][Full Text] [Related]
14. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic changes in the DAP-kinase CpG island in pediatric lymphoma.
Shiramizu B; Mick P
Med Pediatr Oncol; 2003 Dec; 41(6):527-31. PubMed ID: 14595709
[TBL] [Abstract][Full Text] [Related]
16. The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding.
Mulero-Navarro S; Carvajal-Gonzalez JM; Herranz M; Ballestar E; Fraga MF; Ropero S; Esteller M; Fernandez-Salguero PM
Carcinogenesis; 2006 May; 27(5):1099-104. PubMed ID: 16410262
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia.
Garcia-Manero G; Daniel J; Smith TL; Kornblau SM; Lee MS; Kantarjian HM; Issa JP
Clin Cancer Res; 2002 Jul; 8(7):2217-24. PubMed ID: 12114423
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of p15 gene associated with an inferior poor long-term outcome in childhood acute lymphoblastic leukemia.
Mai H; Liu X; Chen Y; Li C; Cao L; Chen X; Chen S; Liu G; Wen F
J Cancer Res Clin Oncol; 2016 Feb; 142(2):497-504. PubMed ID: 26501552
[TBL] [Abstract][Full Text] [Related]
19. Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance.
Narayan G; Freddy AJ; Xie D; Liyanage H; Clark L; Kisselev S; Un Kang J; Nandula SV; McGuinn C; Subramaniyam S; Alobeid B; Satwani P; Savage D; Bhagat G; Murty VV
Genes Chromosomes Cancer; 2011 Dec; 50(12):1043-53. PubMed ID: 21960365
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of two CpG sites upstream of CASP8AP2 promoter influences gene expression and treatment outcome in childhood acute lymphoblastic leukemia.
Li ZG; Jiao Y; Li WJ; Deng GR; Cui L; Gao C; Zhao XX; Wu MY; Jia HT
Leuk Res; 2013 Oct; 37(10):1287-93. PubMed ID: 23953914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]